Payment overview · 2025
General Payments
$13.94
1 reported records · 1 companies
Healthcare provider profile · identity verified
Christopher Richard Brown, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · WILLARD, OH · NPI 1518971563
Verified facts
What the public records show
CMS Open Payments records show Christopher Richard Brown, M.D. received $13.94 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$13.94 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.94 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $13.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 834 | 206 |
| Lisinopril | Lisinopril | 451 | 116 |
| Omeprazole | Omeprazole | 399 | 100 |
| Pantoprazole Sodium | Pantoprazole Sodium | 322 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 318 | 86 |
| Gabapentin | Gabapentin | 280 | 67 |
| Metformin Hcl | Metformin Hcl | 278 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 256 | 66 |
| Amlodipine Besylate | Amlodipine Besylate | 225 | 64 |
| Famotidine | Famotidine | 205 | 51 |
| Potassium Chloride | Potassium Chloride | 205 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 205 | 60 |
| Losartan Potassium | Losartan Potassium | 196 | 58 |
| Furosemide | Furosemide | 189 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 183 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 167 | 29 |
| Eliquis | Apixaban | 166 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 162 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 157 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 132 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 131 | 42 |
| Meloxicam | Meloxicam | 125 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 115 | 34 |
| Ozempic | Semaglutide | 107 | 17 |
| Montelukast Sodium | Montelukast Sodium | 102 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 97 | 43 |
| Jardiance | Empagliflozin | 95 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 29 |
| Allopurinol | Allopurinol | 92 | 22 |
| Carvedilol | Carvedilol | 89 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 88 | 18 |
| Trazodone Hcl | Trazodone Hcl | 84 | 17 |
| Glimepiride | Glimepiride | 83 | 22 |
| Pioglitazone Hcl | Pioglitazone Hcl | 83 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 12 |
| Simvastatin | Simvastatin | 79 | 21 |
| Sertraline Hcl | Sertraline Hcl | 74 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 22 |
| Trulicity | Dulaglutide | 62 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 61 | 17 |
| Prednisone | Prednisone | 59 | 40 |
| Metformin Hcl Er | Metformin Hcl | 57 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 57 | 15 |
| Bupropion Xl | Bupropion Hcl | 56 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 16 |
| Finasteride | Finasteride | 53 | 16 |
| Glipizide | Glipizide | 52 | suppressed |
| Ezetimibe | Ezetimibe | 50 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 13 |
| Synthroid | Levothyroxine Sodium | 47 | 15 |
| Alendronate Sodium | Alendronate Sodium | 46 | 20 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 46 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 45 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 42 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 40 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 40 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 12 |
| Mirtazapine | Mirtazapine | 39 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | 11 |
| Spironolactone | Spironolactone | 39 | 14 |
| Tramadol Hcl | Tramadol Hcl | 39 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | 11 |
| Primidone | Primidone | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 29 |
| Cephalexin | Cephalexin | 36 | 27 |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Alprazolam | Alprazolam | 35 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 35 | 11 |
| Clonazepam | Clonazepam | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 32 | suppressed |
| Colchicine | Colchicine | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Pregabalin | Pregabalin | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 14 |
| Valacyclovir | Valacyclovir Hcl | 31 | 13 |
| Azithromycin | Azithromycin | 30 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Risperidone | Risperidone | 30 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 28 | suppressed |
| Atenolol | Atenolol | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Klor-Con M20 | Potassium Chloride | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 20 |
| Naproxen | Naproxen | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 21 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Cefdinir | Cefdinir | 19 | 17 |
| Celecoxib | Celecoxib | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 15 |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Glipizide Er | Glipizide | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Enbrel Sureclick | Etanercept | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 15 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Livalo | Pitavastatin Calcium | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | 11 |
| Penicillin V Potassium | Penicillin V Potassium | 12 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.94 · 1 records | Medtronic, Inc. | VENASEAL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error